文献速递乳腺外科围术期管理与 ERAS

乳腺手术后阿片类药物处方优化:减少术后阿片处方的研究

Keeping tabs: Reducing postoperative opioid prescriptions for patients after breast surgical procedures.
PubMed 文献 · Surgery · 2021-01-05

本研究为前瞻性单中心研究,纳入2018年10月至2019年所有乳腺手术患者190例,均纳入加速康复外科(ERAS)方案。术后2周问卷评估疼痛及镇痛药使用,发现99%患者被处方阿片类药物,但仅53%使用,且处方药片数均多于实际使用量。结论认为除特殊情况外,所有乳腺手术患者出院时阿片类药物处方可少于10片,并首次提供具体推荐出院用药方案。

要点

  • 99%乳腺手术患者被处方阿片类药物,但仅53%实际使用。
  • 所有患者处方药片数均多于实际使用量。
  • 除特殊情况外,出院阿片处方可少于10片。

核心结论

  • 除特殊情况外,所有乳腺手术患者出院时阿片类药物处方可少于10片。
  • 采用ERAS方案联合标准化出院阿片处方可成功减少阿片处方量。

研究设计与样本

  • 前瞻性单中心研究,纳入2018年10月至2019年所有乳腺手术患者190例,均纳入本院ERAS方案。
  • 术后2周门诊问卷评估围术期疼痛和镇痛药使用,并复习电子病历获取补充信息。
  • 采用适当的参数和非参数检验进行分析。

主要发现

  • 共190例乳腺手术患者完成问卷。
  • 除再切除与乳房切除术之间外,疼痛评分无显著差异。
  • 99%患者被处方阿片类药物,但仅53%使用。
  • 处方阿片类药物的患者中,平均处方药片数均多于实际使用量。

关键数值与推荐

  • 除特殊情况外,所有乳腺手术患者出院阿片类药物处方可少于10片。
  • 本研究首次提供一套具体的推荐出院用药方案。

临床怎么用

  • 乳腺手术后可依据ERAS方案标准化出院阿片处方,将药片数控制在10片以下(特殊情况除外)。
  • 应结合患者实际使用情况减少过度处方。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the opioid crisis continues, it is critical that health care providers ensure they are not overprescribing opioid medications. At our institution (Walter Reed National Military Medical Center, Bethesda, MD), postoperative patients after breast surgeries are discharged with variable amounts of opioid medications. However, many patients report minimal opioid use. The objectives of this study were to characterize postoperative opioid usage and prescribing practices for patients undergoing various breast surgeries and to recommend the number of opioid pills for discharge for each procedure. METHODS: This was a prospective, single-institution study of all patients undergoing breast surgery from October 2018 to 2019. All patients were enrolled in our institution's enhanced recovery after surgery protocol. Patients were given questionnaires at their 2-week postoperative clinic appointment that evaluated perioperative pain and use of pain medications. The electronic medical record was reviewed to obtain additional information. Appropriate parametric and nonparametric tests were used for analysis. RESULTS: A total of 190 breast surgery patients completed the survey. We observed no significant differences in pain scores except between re-excision and mastectomy. Of these patients, 99% were prescribed opioids; however, only 53% of patients used them. Of those patients who were prescribed opioids, on average, all were prescribed more pills than were used. CONCLUSION: Our study demonstrates that it is possible to discharge all breast surgery patients with fewer than 10 opioid pills, except for special circumstances. This is the first study to provide a set of specific recommended discharge medications. Utilization of an enhanced recovery after surgery protocol with standardized discharge opioids can be used successfully to reduce the number of opioids prescribed to patients.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Gunasingha RMKD, Niloy IL, Wetstein BB, et al. Keeping tabs: Reducing postoperative opioid prescriptions for patients after breast surgical procedures. Surgery. 2021. PMID: 33413919. doi:10.1016/j.surg.2020.11.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。